Form: SC 13G/A

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

April 9, 1998

EXHIBIT A

Published on April 9, 1998




Page 7 of 7 pages


EXHIBIT A

AGREEMENT

JOINT FILING OF SCHEDULE 13G


The Undersigned hereby agree to jointly prepare and file with regulatory
authorities a Schedule 13G and any future amendments thereto reporting each of
the undersigned's ownership of securities of Cytoclonal Pharmaceutics Inc. and
hereby affirm that such Schedule 13G is being filed on behalf of each of the
undersigned.




Kinder Investments, L.P.


/s/ Brian A. Wasserman
Dated: April 8, 1998 By:________________________________
New York, New York Brian A. Wasserman
Managing Member
Peyser Associates, LLC





Peyser Associates, LLC


/s/ Brian A. Wasserman
Dated: April 8, 1998 By:_________________________________
New York, New York Brian A. Wasserman
Managing Member





/s/ Brian A. Wasserman
Dated: April 8, 1998 _________________________________
Brian A. Wasserman